ObsEva (NASDAQ:OBSV) Research Coverage Started at StockNews.com

StockNews.com started coverage on shares of ObsEva (NASDAQ:OBSV) in a research report released on Friday morning. The firm issued a hold rating on the stock.

ObsEva Price Performance

Shares of OBSV opened at $0.00 on Friday. ObsEva has a one year low of $0.08 and a one year high of $2.14. The company has a 50-day moving average of $0.03 and a two-hundred day moving average of $0.04. The stock has a market cap of $31,188.40, a price-to-earnings ratio of 0.00 and a beta of 0.68.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the company. Credit Suisse AG boosted its holdings in shares of ObsEva by 11.0% during the fourth quarter. Credit Suisse AG now owns 1,750,573 shares of the company’s stock worth $255,000 after purchasing an additional 173,455 shares during the period. Two Sigma Investments LP bought a new position in ObsEva during the third quarter valued at approximately $25,000. Millennium Management LLC bought a new position in ObsEva during the second quarter valued at approximately $192,000. Bank of America Corp DE raised its position in ObsEva by 54,142.2% during the first quarter. Bank of America Corp DE now owns 484,383 shares of the company’s stock valued at $731,000 after acquiring an additional 483,490 shares in the last quarter. Finally, Virtu Financial LLC bought a new position in ObsEva during the first quarter valued at approximately $30,000. 17.52% of the stock is currently owned by institutional investors and hedge funds.

ObsEva Company Profile

ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women’s reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland.